[Combined Intense Pulsed Light and low-level light therapy in the treatment of Meibomian gland dysfunction]. / Traitement combiné par lumière intense pulsée et thérapie par lumière de faible niveau dans le dysfonctionnement des glandes de Meibomius.
J Fr Ophtalmol
; 44(7): 1021-1028, 2021 Sep.
Article
en Fr
| MEDLINE
| ID: mdl-34172298
ABSTRACT
INTRODUCTION:
Meibomian gland dysfunction (MGD) is the most common cause of dry eye syndrome. The goal of this study was to evaluate the efficacy of combined intense pulsed light (IPL) and low-level light therapy (LLLT) in symptomatic MGD. MATERIALS ANDMETHODS:
This retrospective study analyzed data from 30 patients with MGD causing dry eye symptoms not relieved by medical therapy and managed with combined IPL and LLLT. The primary endpoint was the Ocular Score Disease Index (OSDI) score at 1 month and 1 year. Secondary endpoints were visual acuity, intraocular pressure, tear film break-up time, Schirmer's test, Oxford score, and infrared meibographic score at 1 month after the conclusion of treatment.RESULTS:
The mean OSDI score decreased from 43±19 to 17±12 (1 month; p<0.0001) and then to 29±11 (12 months; p=0.013); 63% of patients were meibographic grade 2 before versus 7% after treatment (range, 1-4) (p=0.009); 75% of patients were Oxford grade 1 before versus 41% after treatment (p=0.004) (range, 1-3). No significant difference in the other secondary endpoints was noted.CONCLUSION:
Over time, IPL therapy in combination with LLLT appears to improve patients with symptomatic MGD resistant to medical therapy.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Terapia por Luz de Baja Intensidad
/
Disfunción de la Glándula de Meibomio
Tipo de estudio:
Observational_studies
Límite:
Humans
Idioma:
Fr
Revista:
J Fr Ophtalmol
Año:
2021
Tipo del documento:
Article
País de afiliación:
Francia